Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487643 · ClinicalTrials.gov registry record
Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay
A clinical trial, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00487643: Completed study, sponsored by Walter Reed Army Medical Center.
NCT00487643 is a clinical trial that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00487643 has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Purpose: to build a library of normal tear lacritin values by collecting tears from normal adult human subjects and to develop a non-invasive clinical assay for lacritin. Such an assay will provide more sensitive indicators of eye disease for clinicians and determine if a particular therapy, such as recombinant lacritin drops, is of benefit.
Interventions
- PROCEDURE Tear Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-05 |
| Est. Completion | 2014-03 |
What the finished NCT00487643 record still lists
NCT00487643 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Tear Collection is the first listed.
NCT00487643 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00487643 about?
NCT00487643 is a clinical study titled "Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay". Purpose: to build a library of normal tear lacritin values by collecting tears from normal adult human subjects and to develop a non-invasive clinical assay for lacritin. Such an assay will provide more sensitive indicators of eye disease for clinicians and determine if a particular therapy, such as...
What is the current status of trial NCT00487643?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-05. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00487643?
The interventions under investigation include: Tear Collection (PROCEDURE).
Who is sponsoring clinical trial NCT00487643?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia